| |
| |
|
| Insider
Information: |
Cox Geoffrey F |
| Relationship: |
Interim CEO, Director |
| City: |
Framingham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
184,590 |
|
|
Indirect Shares
|
5,343 |
|
|
| Direct
Value |
$81,300 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
189,933 |
|
|
| Total
Value |
$81,300 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vaxart Inc |
VXRT |
Director |
2010-05-20 |
25,679 |
2003-08-11 |
0 |
Premium* |
|
|
GTC Biotherapeutics Inc |
GTCB |
President, CEO and Cha... |
2009-11-02 |
80,411 |
2009-11-02 |
5,343 |
Premium* |
|
|
Novelion Therapeutics Inc |
NVLN |
Interim CEO, Director |
2015-06-29 |
78,500 |
2014-12-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GTCB |
GTC Biotherapeutics Inc |
President, CEO and Chairman |
• • – |
2007-03-14 |
4 |
B |
$0.99 |
$24,157 |
D/D |
24,000 |
228,694 |
2.81 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
President, CEO and Chairman |
• • – |
2007-07-06 |
4 |
A |
$1.01 |
$1,274 |
D/D |
1,260 |
227,764 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
President, CEO and Chairman |
• • – |
2007-08-13 |
4 |
B |
$1.02 |
$14,549 |
D/D |
14,200 |
241,964 |
2.81 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
President, CEO and Chairman |
• • – |
2006-11-06 |
4 |
B |
$1.05 |
$15,127 |
D/D |
14,300 |
203,434 |
2.81 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
officerTitle |
• • – |
2005-10-07 |
4 |
A |
$1.12 |
$1,176 |
D/D |
1,048 |
93,344 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
President, CEO and Chairman |
• • – |
2009-11-02 |
4/A |
D |
$1.21 |
$13,544 |
D/D |
(11,193) |
80,411 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
President, CEO and Chairman |
• • – |
2009-11-02 |
4/A |
A |
$1.21 |
$42,696 |
D/D |
35,286 |
91,604 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
President, CEO and Chairman |
• • – |
2009-11-02 |
4 |
A |
$1.21 |
$38,267 |
D/D |
31,626 |
87,944 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
President, CEO and Chairman |
• • – |
2006-08-10 |
4 |
A |
$1.23 |
$1,230 |
D/D |
1,000 |
187,960 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
President, CEO and Chairman |
• • – |
2004-10-08 |
4 |
A |
$1.31 |
$971 |
D/D |
741 |
65,551 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
President, CEO and Chairman |
• • – |
2005-06-24 |
4 |
A |
$1.37 |
$1,007 |
D/D |
736 |
92,296 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
officerTitle |
• • – |
2005-12-30 |
4 |
A |
$1.39 |
$1,008 |
D/D |
723 |
93,517 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
President, CEO and Chairman |
• • – |
2005-01-07 |
4 |
A |
$1.44 |
$996 |
D/D |
692 |
66,243 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
President, CEO and Chairman |
• • – |
2004-07-09 |
4 |
A |
$1.70 |
$1,294 |
D/D |
761 |
64,810 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
President, CEO and Chairman |
• • – |
2005-03-15 |
4 |
B |
$1.79 |
$9,529 |
D/D |
5,300 |
85,300 |
2.81 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Chairman, President and CEO |
• • – |
2004-03-19 |
4 |
A |
$2.15 |
$4,951 |
D/D |
2,300 |
63,536 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
President, CEO and Chairman |
• • – |
2004-04-08 |
4 |
A |
$2.20 |
$1,129 |
D/D |
513 |
64,049 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
officerTitle |
• • – |
2003-09-26 |
4 |
A |
$2.34 |
$968 |
D/D |
414 |
43,414 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
officerTitle |
• • – |
2003-08-11 |
4 |
B |
$2.40 |
$4,947 |
D/D |
2,000 |
43,000 |
2.73 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
President, CEO and Chairman |
• • – |
2003-12-29 |
4 |
A |
$2.53 |
$1,132 |
D/D |
447 |
43,861 |
|
- |
|
| GTCB |
GTC Biotherapeutics Inc |
President, CEO and Chairman |
• • – |
2009-06-30 |
4 |
D |
$2.66 |
$6,200 |
D/D |
(2,331) |
56,318 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2005-05-27 |
4 |
OE |
$3.25 |
$24,375 |
D/D |
7,500 |
20,479 |
|
- |
|
| NVLN |
Novelion Therapeutics Inc |
Interim CEO |
• • – |
2015-06-29 |
4 |
OE |
$3.61 |
$262,475 |
D/D |
72,500 |
78,500 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-05-20 |
4 |
B |
$5.24 |
$9,998 |
D/D |
1,908 |
25,679 |
2.39 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2003-08-11 |
4 |
B |
$5.45 |
$4,905 |
D/D |
900 |
10,002 |
2.31 |
- |
|
54 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
